Sandoz, Teva and Viatris are navigating generic drug pricing pressure with scale, complex generics and cost cuts.

The private equity major picks up minority stake in Ireland's Felix Pharma, betting on fast-growing global market for generic ...

Patent settlements accelerate the entry of generics and biosimilars, saving the health care system $422.9 billion and ...